Haemonetics Corp reports results for the quarter ended in June - Earnings Summary

Haemonetics

08/08/2023 12:44

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
$1.05​​ per share for the quarter ended in June. The mean
expectation of eight analysts for the quarter was for earnings
of 73 cents per share.
    * Revenue rose 19.1% to $311.33 million from a year ago;
analysts
expected $292.69 million. 
    * Haemonetics Corp's reported EPS for the quarter was 80
cents​.
    * The mean earnings estimate of analysts had risen by
about 5.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Haemonetics Corp shares had risen by 4.1% this quarter and
gained 12.7% so far this year.
    * The company reported quarterly net income of $41.04
million.
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $105.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 11:43 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.73           1.05           Beat
 Mar. 31 2023      0.70           0.77           Beat
 Dec. 31 2022      0.80           0.85           Beat
 Sep. 30 2022      0.67           0.83           Beat